24Business
GSK reports fall into profit due to Fallout Zantaca -but increases the goal of 2031 revenue to $ 40 billion due to booming on cancer sales
“We expect another year of profitable growth in 2025 and we further improved our long -term odds,” said Walmsley CEO. Read more
Source link
